September 1st, 2009, by Digital Davo | acne treatments, aczone
The FDA has issued a warning letter to Allergan, the makers of Aczone for overstating the efficacy of Aczone and also for understating the possible side effects. In a sign that the FDA is watching carefully the claims that vendors use when advertising their products, the warning letter calls out a journal advertisement for Aczone as violating the Federal Food, Drug, and Cosmetic Act. …
June 19th, 2008, by Digital Davo | acne treatments, aczone, in the news, topicals
OK this story is getting so much coverage in the online press that I thought I should cover it here too. Allergan is buying the topical dapsone product called Aczone for $150m.
From: Allergan Announces Agreement to Acquire Aczone(R) Gel 5%
“Aczone(R) Gel 5% …
April 10th, 2006, by Digital Davo | aczone, clinical trials, natural remedies, topicals
A large Phase II Clinical Trial for treating rosacea with Aczone is looking for participants. The trial aims to compare Aczone (5% topical dapsone gel) with the vehicle and Metrogel 1%.
The purpose of this study is to evaluate the safety and effectiveness of ACZONE gel compared to placebo (inactive substance), MetroGel and a combination of ACZONE gel and MetroGel for the treatment of rosacea.
ACZONE gel, …
August 22nd, 2005, by Digital Davo | aczone, topicals
The U.S. Food and Drug Administration (FDA) has approved Aczone (dapsone) Gel, 5% for the topical treatment of acne vulgaris in patients 12 years and older.
Aczone is an aqueous topical gel containing 5% dapsone. Aczone has been shown to achieve statistically significant percent reduction in the number of acne lesions and better success rate on the Global Acne Assessment Score. Like many acne treatments, …
|
|
|
|
|
|